Literature DB >> 28230640

Disparities in Waitlist and Posttransplantation Outcomes in Liver Transplant Registrants and Recipients Aged 18 to 24 Years: Analysis of the UNOS Database.

Noelle H Ebel1, Evelyn K Hsu, Kristin Berry, Simon P Horslen, George N Ioannou.   

Abstract

BACKGROUND: We evaluated liver transplantation waitlist and posttransplantation outcomes in those aged 18 to 24 years compared with both younger (0-17 years) and older (25-34 years) registrants and recipients.
METHODS: Using national data from the United Network for Organ Sharing, competing risk, Cox regression and Kaplan-Meier analyses were performed on first-time liver transplant registrants (n = 13 979) and recipients (n = 8718) ages 0 to 34 years between 2002 and 2015.
RESULTS: Nonstatus 1A registrants, registrants aged 0 to 17 and 25 to 34 years were less likely to experience dropout from the waiting list compared with those aged 18 to 24 years (adjusted hazard ratio, 0-5 years = 0.36; 6-11 = 0.29; 12-17 = 0.48; 18-24 = 1.00; 25-34 = 0.82). Although there was no difference in risk of graft failure across all age groups, both younger and older age groups had significantly lower risk of posttransplant mortality compared with those aged 18 to 24 years (adjusted hazard ratio, for 0-5 years = 0.53, 6-11 = 0.48, 12-17 = 0.70, 18-24 = 1.00, 25-34 = 0.77). This may be related to lower likelihood of retransplantation after graft failure in those aged 18 to 24 years.
CONCLUSIONS: This national registry study demonstrates for the first time poorer waitlist and postliver transplant outcomes in young adults ages 18 to 24 years at the time of listing and transplantation compared to older and younger age groups. Given the potential survival benefit in transplanting young adults and the shortage of solid organs for transplant, future studies are critical to identify and target modifiable risk factors to improve waitlist and long-term posttransplant outcomes in 18- to 24-year-old registrants and recipients.

Entities:  

Mesh:

Year:  2017        PMID: 28230640      PMCID: PMC5481466          DOI: 10.1097/TP.0000000000001689

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  28 in total

1.  Model for end-stage liver disease (MELD) exception for unusual metabolic liver diseases.

Authors:  Sue McDiarmid; Robert G Gish; Simon Horslen; George V Mazariegos
Journal:  Liver Transpl       Date:  2006-12       Impact factor: 5.799

2.  OPTN/SRTR 2013 Annual Data Report: liver.

Authors:  W R Kim; J R Lake; J M Smith; M A Skeans; D P Schladt; E B Edwards; A M Harper; J L Wainright; J J Snyder; A K Israni; B L Kasiske
Journal:  Am J Transplant       Date:  2015-01       Impact factor: 8.086

3.  Across all solid organs, adolescent age recipients have worse transplant organ survival than younger age children: A US national registry analysis.

Authors:  Vikas R Dharnidharka; Kenneth E Lamb; Jie Zheng; Kenneth B Schechtman; Herwig-Ulf Meier-Kriesche
Journal:  Pediatr Transplant       Date:  2015-04-01

4.  Impact of graft size mismatching on graft prognosis in liver transplantation from living donors.

Authors:  T Kiuchi; M Kasahara; K Uryuhara; Y Inomata; S Uemoto; K Asonuma; H Egawa; S Fujita; M Hayashi; K Tanaka
Journal:  Transplantation       Date:  1999-01-27       Impact factor: 4.939

Review 5.  Improving liver allocation: MELD and PELD.

Authors:  Richard B Freeman; Russell H Wiesner; John P Roberts; Suzanne McDiarmid; Dawn M Dykstra; Robert M Merion
Journal:  Am J Transplant       Date:  2004       Impact factor: 8.086

6.  Studies of Pediatric Liver Transplantation 2002: patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada.

Authors:  S R Martin; P Atkison; R Anand; A S Lindblad
Journal:  Pediatr Transplant       Date:  2004-06

7.  Quality Improvement Targeting Adherence During the Transition from a Pediatric to Adult Liver Transplant Clinic.

Authors:  Emily M Fredericks; John C Magee; Sally J Eder; Jessica R Sevecke; Dawn Dore-Stites; Victoria Shieck; M James Lopez
Journal:  J Clin Psychol Med Settings       Date:  2015-09

8.  Center variation in the use of nonstandardized model for end-stage liver disease exception points.

Authors:  David S Goldberg; George Makar; Therese Bittermann; Benjamin French
Journal:  Liver Transpl       Date:  2013-10-10       Impact factor: 5.799

9.  High Risk of Liver Allograft Failure During Late Adolescence and Young Adulthood.

Authors:  Bethany J Foster; Mourad Dahhou; Xun Zhang; Vikas R Dharnidharka; Jennifer Conway; Vicky Lee Ng
Journal:  Transplantation       Date:  2016-03       Impact factor: 4.939

10.  Nonstandard Exception Requests Impact Outcomes for Pediatric Liver Transplant Candidates.

Authors:  H J Braun; E R Perito; J L Dodge; S Rhee; J P Roberts
Journal:  Am J Transplant       Date:  2016-06-27       Impact factor: 8.086

View more
  1 in total

1.  Impact of Payer Status on Delisting Among Liver Transplant Candidates in the United States.

Authors:  Krystal L Karunungan; Yas Sanaiha; Roland A Hernandez; Holly Wilhalme; Sarah Rudasill; Joseph Hadaya; Joseph DiNorcia; Peyman Benharash
Journal:  Liver Transpl       Date:  2020-12-31       Impact factor: 5.799

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.